ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,686Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 1006

$781K Total Retail Price of All Prescriptions

Rank: 85 out of 1006

315 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 315 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 315 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 550 465 1 4
METOPROLOL SUCCINATE 333 304 2 12
LEVOTHYROXINE SODIUM 283 268 3 2
ATORVASTATIN CALCIUM 234 222 4 5
METFORMIN HCL 233 194 5 10
BENICAR 230 219 6 78
METOPROLOL TARTRATE 221 212 7 7
SIMVASTATIN 213 196 8 1
LISINOPRIL 202 189 9 3
FUROSEMIDE 193 187 10 6
NEXIUM 193 133 10 28
CRESTOR 184 183 12 18
OXYCODONE HCL 176 64 S2 13 54
PANTOPRAZOLE SODIUM 151 128 14 32
CLOPIDOGREL 149 140 15 46
PRAVASTATIN SODIUM 136 122 16 15
AVODART 132 132 17 209
ZOLPIDEM TARTRATE 132 127 17 14
HYDROCHLOROTHIAZIDE 127 101 19 11
OMEPRAZOLE 111 102 20 9
DIOVAN 109 82 21 16
DILTIAZEM 24HR ER 109 105 21 126
PLAVIX 98 94 23 61
ISOSORBIDE MONONITRATE ER 93 92 24 59
DONEPEZIL HCL 89 89 25 17
SPIRIVA 85 84 26 48
GABAPENTIN 85 68 26 20
BENICAR HCT 84 82 28 120
ZETIA 84 84 28 51
LEVOFLOXACIN 83 63 30 96
HYDROCODONE-ACETAMINOPHEN 77 74 S3 31 25
SERTRALINE HCL 75 73 32 19
LOVAZA 73 66 33 157
GLYBURIDE 73 61 R 33 65
LIDODERM 70 63 35 66
ATENOLOL 69 65 36 13
WARFARIN SODIUM 69 69 36 8
ADVAIR DISKUS 68 66 38 37
ALENDRONATE SODIUM 67 62 39 29
FENTANYL 65 28 S2 40 74
CYMBALTA 64 48 41 41
TAMSULOSIN HCL 64 64 41 23
OXYCONTIN 62 30 S2 43 98
DIOVAN HCT 60 60 44 60
CARVEDILOL 55 53 45 36
PREDNISONE 54 41 46 33
VOLTAREN 53 46 47 251
NAMENDA 53 52 47 34
LOSARTAN POTASSIUM 51 34 49 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.